Healthcare provider profile · identity verified

Mark Walter Olson, M.D.

Family Practice · MUNISING, MI · NPI 1043254626

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	334	71
Omeprazole	Omeprazole	242	52
Amlodipine Besylate	Amlodipine Besylate	238	45
Losartan Potassium	Losartan Potassium	237	52
Eliquis	Apixaban	224	30
Hydrochlorothiazide	Hydrochlorothiazide	188	39
Tamsulosin Hcl	Tamsulosin Hcl	181	36
Metoprolol Succinate	Metoprolol Succinate	174	34
Levothyroxine Sodium	Levothyroxine Sodium	169	38
Lisinopril	Lisinopril	168	37
Pravastatin Sodium	Pravastatin Sodium	154	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	29
Rosuvastatin Calcium	Rosuvastatin Calcium	144	30
Furosemide	Furosemide	133	28
Gabapentin	Gabapentin	126	22
Metformin Hcl Er	Metformin Hcl	108	23
Carvedilol	Carvedilol	99	18
Simvastatin	Simvastatin	98	18
Albuterol Sulfate Hfa	Albuterol Sulfate	97	24
Potassium Chloride	Potassium Chloride	89	15
Montelukast Sodium	Montelukast Sodium	86	16
Metformin Hcl	Metformin Hcl	77	15
Zolpidem Tartrate	Zolpidem Tartrate	76	14
Sertraline Hcl	Sertraline Hcl	68	13
Glimepiride	Glimepiride	61	11
Chlorthalidone	Chlorthalidone	60	13
Mirtazapine	Mirtazapine	59	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	11
Metoprolol Tartrate	Metoprolol Tartrate	56	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	11
Tramadol Hcl	Tramadol Hcl	54	suppressed
Warfarin Sodium	Warfarin Sodium	54	suppressed
Alprazolam	Alprazolam	53	12
Trazodone Hcl	Trazodone Hcl	51	11
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	suppressed
Lorazepam	Lorazepam	48	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	11
Alendronate Sodium	Alendronate Sodium	45	12
Clonazepam	Clonazepam	41	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Spironolactone	Spironolactone	38	suppressed
Allopurinol	Allopurinol	37	suppressed
Atenolol	Atenolol	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Ozempic	Semaglutide	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Enalapril Maleate	Enalapril Maleate	33	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Bumetanide	Bumetanide	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	16
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Glipizide	Glipizide	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Jardiance	Empagliflozin	24	suppressed
Clonidine	Clonidine	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	23	20
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	22	suppressed
Prednisone	Prednisone	22	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Digoxin	Digoxin	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Estradiol	Estradiol	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Finasteride	Finasteride	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Valsartan	Valsartan	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Baclofen	Baclofen	13	suppressed
Eplerenone	Eplerenone	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Famotidine	Famotidine	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Azithromycin	Azithromycin	11	11
Mesalamine	Mesalamine	11	suppressed
Metolazone	Metolazone	11	suppressed
Primidone	Primidone	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Torsemide	Torsemide	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error